The U-IGHV status, del (17p)/TP53 mutations or del (11q)/ATM deletions were more frequently seen in CLL with CK, than in CL without CK (Figure 3) [22–24, 28–29, 39, 61–63]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.